Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, ConvaTec Group's Enterprise Value is $7,716 Mil.
ConvaTec Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $241 Mil. Therefore, ConvaTec Group's EV-to-EBIT ratio for today is 32.06.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, ConvaTec Group's Enterprise Value is $7,716 Mil.
ConvaTec Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $456 Mil. Therefore, ConvaTec Group's EV-to-EBITDA ratio for today is 16.94.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, ConvaTec Group's Enterprise Value is $7,716 Mil.
ConvaTec Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $2,142 Mil. Therefore, ConvaTec Group's EV-to-Revenue ratio for today is 3.60.
ConvaTec Group Enterprise Value Historical Data
The historical data trend for ConvaTec Group's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ConvaTec Group's Enterprise Value
For the Medical Instruments & Supplies subindustry, ConvaTec Group's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ConvaTec Group's Enterprise Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ConvaTec Group's Enterprise Value distribution charts can be found below:
* The bar in red indicates where ConvaTec Group's Enterprise Value falls into.
ConvaTec Group Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
ConvaTec Group's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ConvaTec Group (OTCPK:CNVVF) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
ConvaTec Group's current Enterprise Value is $7,716 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. ConvaTec Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $241 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
ConvaTec Group's current Enterprise Value is $7,716 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. ConvaTec Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $456 Mil.
ConvaTec Group's current Enterprise Value is $7,716 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. ConvaTec Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $2,142 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ConvaTec Group Enterprise Value Related Terms
Thank you for viewing the detailed overview of ConvaTec Group's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
ConvaTec Group (ConvaTec Group) Business Description
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and continence care are the largest divisions, accounting for 30% and 26% of total revenue, respectively. Ostomy contributes 25% of revenue and infusion sets 19%.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CNVVF has been successfully added to your 